Coscia A, Kumar A, Jandzinski M, Swany L, Fuster F, Ahn J
PLoS One. 2025; 20(2):e0318993.
PMID: 40009588
PMC: 11864553.
DOI: 10.1371/journal.pone.0318993.
Zhang C, Su X, Zhang Y, He P, Kong X, Zhang Z
Nat Sci Sleep. 2025; 17:343-356.
PMID: 40008303
PMC: 11853869.
DOI: 10.2147/NSS.S495071.
Ma H, Xu F, Liu L, Kong H, Luo R, Liu M
Int J Cardiol Heart Vasc. 2025; 56:101605.
PMID: 39897413
PMC: 11783049.
DOI: 10.1016/j.ijcha.2025.101605.
Liu Y, Wang C, Li M, Zhu Y, Liu K, Liu Y
Front Pharmacol. 2025; 15:1507194.
PMID: 39759448
PMC: 11695318.
DOI: 10.3389/fphar.2024.1507194.
Zhu H, Li C, Hu F, Wu L, Wu L, Zhou M
In Vitro Cell Dev Biol Anim. 2024; 61(1):107-116.
PMID: 39621175
DOI: 10.1007/s11626-024-00976-2.
Mesenchymal Stem Extracellular Vesicles in Various Respiratory Diseases: A New Opportunity.
Hu Z, Zhu L, Zhu Y, Xu Y
J Inflamm Res. 2024; 17:9041-9058.
PMID: 39583853
PMC: 11586120.
DOI: 10.2147/JIR.S480345.
Baseline triglyceride-glucose, body mass index, end-diastolic internal diameter of the left atria and creatinine are independent predictors for pulmonary hypertension in coronary artery disease patients after percutaneous coronary intervention....
Xie L, Fu S, Xu Y, Ran L, Luo J, Rao R
Biomark Med. 2024; 18(23):1049-1059.
PMID: 39564778
PMC: 11633393.
DOI: 10.1080/17520363.2024.2422807.
Hormone Replacement Therapy and Pulmonary Hypertension: A Review of the Literature.
Gill N, Sohi S, Joseph G, Bhatti N
Cureus. 2024; 16(10):e71908.
PMID: 39564039
PMC: 11576071.
DOI: 10.7759/cureus.71908.
Assessing personalized molecular portraits underlying endothelial-to-mesenchymal transition within pulmonary arterial hypertension.
Wu R, Zhang G, Guo M, Li Y, Qin L, Jiang T
Mol Med. 2024; 30(1):189.
PMID: 39462326
PMC: 11513636.
DOI: 10.1186/s10020-024-00963-z.
Effects of the ACE2-Ang-(1-7)-Mas axis on gut flora diversity and intestinal metabolites in SuHx mice.
Abudukeremu A, Aikemu A, Yang T, Fang L, Aihemaitituoheti A, Zhang Y
Front Microbiol. 2024; 15:1412502.
PMID: 39247700
PMC: 11380154.
DOI: 10.3389/fmicb.2024.1412502.
miR-135b: An emerging player in cardio-cerebrovascular diseases.
Shao Y, Xu J, Chen W, Hao M, Liu X, Zhang R
J Pharm Anal. 2024; 14(10):100997.
PMID: 39211791
PMC: 11350494.
DOI: 10.1016/j.jpha.2024.100997.
Levosimendan mediates the BMP/Smad axis through upregulation of circUSP34-targeted miR-1298 to alleviate pulmonary hypertension.
Meng Q, Song L, Wang H, Wang G, Zhou G
Respir Res. 2024; 25(1):316.
PMID: 39160536
PMC: 11334555.
DOI: 10.1186/s12931-024-02945-5.
Inhibition of RUNX1 slows the progression of pulmonary hypertension by targeting CBX5.
Ma X, Cao Y, Yang D, Dong Z, Wang X
Biomol Biomed. 2024; 25(2):472-481.
PMID: 39151099
PMC: 11734815.
DOI: 10.17305/bb.2024.10720.
Cell Death in Pulmonary Arterial Hypertension.
Li X, Tan J, Wan J, Cheng B, Wang Y, Dai A
Int J Med Sci. 2024; 21(10):1840-1851.
PMID: 39113898
PMC: 11302558.
DOI: 10.7150/ijms.93902.
Mendelian randomization study on causal association of TEF and circadian rhythm with pulmonary arterial hypertension.
Chen D, Jin Q, Yang L, Zhang X, Li M, Zhang L
Respir Res. 2024; 25(1):301.
PMID: 39113039
PMC: 11308427.
DOI: 10.1186/s12931-024-02934-8.
Legumain in cardiovascular diseases.
Zhou L, Wu J, Wei Z, Zheng Y
Exp Biol Med (Maywood). 2024; 249:10121.
PMID: 39104790
PMC: 11298360.
DOI: 10.3389/ebm.2024.10121.
Riociguat as bridging therapy to pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a retrospective cohort study.
Zhang Z, Liu J, Zhen Y, Liu X, Xu M, Ma J
J Thorac Dis. 2024; 16(6):3540-3552.
PMID: 38983143
PMC: 11228705.
DOI: 10.21037/jtd-24-48.
Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003-2018.
Liu Z, Fu Q, Yu Q, Ma X, Yang R
Front Endocrinol (Lausanne). 2024; 15:1418835.
PMID: 38952391
PMC: 11215008.
DOI: 10.3389/fendo.2024.1418835.
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in Patients with Lupus Nephritis.
Chen S, Guo J, Huang X, He W, Yu X, Xia X
Medicina (Kaunas). 2024; 60(6).
PMID: 38929605
PMC: 11205415.
DOI: 10.3390/medicina60060988.
Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota.
Yang Y, Zhang H, Wang Y, Xu J, Shu S, Wang P
Imeta. 2024; 3(2):e159.
PMID: 38882495
PMC: 11170974.
DOI: 10.1002/imt2.159.